| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1000464924 |
| P356 | DOI | 10.1186/1471-2369-10-42 |
| P932 | PMC publication ID | 2800106 |
| P698 | PubMed publication ID | 20003546 |
| P5875 | ResearchGate publication ID | 40681411 |
| P50 | author | Jason A. Roberts | Q38544404 |
| Helen Healy | Q39758561 | ||
| Jeffrey Lipman | Q53678222 | ||
| Dwarakanathan Ranganathan | Q57009915 | ||
| Robert G Fassett | Q96177747 | ||
| Julie M Varghese | Q114430317 | ||
| P2093 | author name string | Vincent D'Intini | |
| P2860 | cites work | A suggested approach to once‐daily aminoglycoside dosing | Q34347273 |
| Predicting efficacy of antiinfectives with pharmacodynamics and Monte Carlo simulation | Q35582365 | ||
| Peritoneal dialysis-related infections recommendations: 2005 update. | Q36082727 | ||
| Drug therapy in patients undergoing continuous ambulatory peritoneal dialysis. Clinical pharmacokinetic considerations | Q37909313 | ||
| Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis | Q38498996 | ||
| Pharmacokinetics of intraperitoneal cefazolin and gentamicin in empiric therapy of peritonitis in continuous ambulatory peritoneal dialysis patients | Q39530811 | ||
| Pharmacokinetics of gentamicin in patients undergoing continuous ambulatory peritoneal dialysis | Q39854882 | ||
| Single UK centre experience on the treatment of PD peritonitis--antibiotic levels and outcomes | Q40232400 | ||
| Statistical considerations in pharmacokinetic study design | Q40913170 | ||
| Pharmacokinetics of once-daily IP gentamicin in CAPD patients | Q42641068 | ||
| Empirical aminoglycosides for peritonitis do not affect residual renal function | Q44338076 | ||
| Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration | Q44483617 | ||
| Effectiveness of once-weekly vancomycin and once-daily gentamicin, intraperitoneally, for CAPD peritonitis | Q44617559 | ||
| A quarter of a century of adult peritoneal dialysis-related peritonitis at an Australian medical center. | Q45004793 | ||
| Systemic absorption of intraperitoneal antimicrobials in continuous ambulatory peritoneal dialysis | Q46917343 | ||
| A survey of CAPD peritonitis management and outcomes in North and South Thames NHS regions (U.K.): support for the ISPD guidelines. International Society for Peritoneal Dialysis. | Q53334870 | ||
| Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients. | Q53934025 | ||
| Once-daily intraperitoneal gentamicin is effective therapy for gram-negative CAPD peritonitis. | Q54077221 | ||
| Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients. | Q54105034 | ||
| Treatment of peritonitis in continuous ambulatory peritoneal dialysis (CAPD) with intraperitoneal cefazolin and gentamicin | Q69155183 | ||
| Postantibiotic effects | Q70073524 | ||
| A prospective randomized comparison of single versus multidose gentamicin in the treatment of CAPD peritonitis | Q70819168 | ||
| Peritoneal pharmacokinetics of gentamicin in man | Q71704148 | ||
| Tobramycin kinetics during continuous ambulatory peritoneal dialysis | Q71761959 | ||
| Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002-2003 | Q83873534 | ||
| Aminoglycosides--50 years on | Q95806228 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | renal dialysis | Q202301 |
| gentamicin | Q422482 | ||
| peritoneal dialysis | Q1756474 | ||
| P304 | page(s) | 42 | |
| P577 | publication date | 2009-12-16 | |
| P1433 | published in | BMC Nephrology | Q15750891 |
| P1476 | title | Optimising intraperitoneal gentamicin dosing in peritoneal dialysis patients with peritonitis (GIPD) study | |
| P478 | volume | 10 |
| Q42104270 | ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment |
| Q37195374 | Peritoneal dialysis associated infections: An update on diagnosis and management |
| Q40110478 | Pharmacokinetics of Intraperitoneal Cefalothin and Cefazolin in Patients Being Treated for Peritoneal Dialysis-Associated Peritonitis |
| Q36126934 | Pharmacokinetics of intraperitoneal gentamicin in peritoneal dialysis patients with peritonitis (GIPD study). |
| Q24195002 | Treatment for peritoneal dialysis-associated peritonitis |
Search more.